Dyadic posts strategic presentation; no specific financial or operational updates

DYADIC INTERNATIONAL INC

Presentation posted July 23, 2025 highlights transition from research to commercial focus.
Focus on C1 and Dapibus gene expression platforms for non-therapeutic protein production.
No specific financial targets, revenue guidance, or operational metrics disclosed.
Presentation will be used at industry and investor conferences.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.